TINA-QUANT HBALC GEN. 3
Received Jun 16, 2022 · Event occurred Jun 1, 2022
Report 1823260-2022-01758 · MDR key 14715740
Device
Generic name
Assay, Glycosylated Hemoglobin
Manufacturer
Roche DiagnosticsModel number
HBA1C TQ G3Catalog number
05336163190
Lot number
59190201
Product problems
- High Test Results
- High Test Results
Patient
68 YR · Female
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Description of Event or Problem
THE INITIAL REPORTER RECEIVED QUESTIONABLE HBA1C TQ GEN.3 RESULTS ON A COBAS INTEGRA 400 PLUS ANALYZER. DUE TO A CLIENT QUESTIONING REPORTED HBA1C RESULTS, THE REPORTER REPEATED PREVIOUS PATIENT SAMPLES ON THE SAME ANALYZER. FOR PATIENT SAMPLE #(B)(6), THE INITIAL HBA1C RESULT WAS 8.1%. THE REPEAT HBA1C RESULT WAS 6.4%. THE INITIAL RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS COLLECTED AND INITIALLY RUN ON (B)(6) 2022. THE REPEAT TEST WAS PERFORMED ON THE SAME SAMPLE AND ANALYZER ON (B)(6) 2022. THE INSTRUMENT SERIAL NUMBER IS (B)(4).
Additional Manufacturer Narrative
THE FIELD SERVICE ENGINEER (FSE) PERFORMED A PRECISION STUDY THAT WAS ACCEPTABLE. THE FSE FOUND THAT WASH PROBE C HAD FAILED THE THROUGHPUT CHECK AND WAS NOT DISPENSING FLUID. HE REPLACED TWO VALVES, RESEATED AND REPLACED BOARDS, AND REPLACED THE CASSETTE SENSE LOCK MODULE. THE CUSTOMER SUCCESSFULLY PERFORMED CALIBRATION AND QC. AS THE QC RECOVERY WAS WITHIN 2SD, THERE WAS NO INDICATION OF A PERFORMANCE ISSUE OF THE REAGENT. THE SERVICE ACTIONS PERFORMED BY THE FSE RESOLVED THE ISSUE.